Mutations and/or copy loss of TP53 and RB1 were found in majority of plasma and tumor (55 of 61 [90.2%] and 51 of 61, [83.6%], respectively), consistent with the frequent inactivation of these genes in SCLC [23]. This evidence concerns the gene TP53 and neoplasm.